Penicillin or Ceftriaxone for Neurosyphilis in People With HIV: A Retrospective, Propensity Score–Matched Multicenter Study in Mexico
Open Forum Infectious Diseases · 01.07.2026 · 13 (7)
DOI: 10.1093/ofid/ofag387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 13.07.2026. Verfasst von Rodrigo Ville Benavides und 16 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Neurosyphilis, ocular syphilis, and otosyphilis occur more frequently among people with HIV-1 and are associated with higher morbidity and treatment failure. Intravenous penicillin G remains the standard therapy but requires hospitalization or prolonged intravenous access, creating barriers that are amplified in resource-limited settings facing recurrent penicillin shortages. Ceftriaxone is a potential alternative; however, comparative data in people with HIV are limited.
Methods
We conducted a multicenter retrospective cohort study of adults with HIV at 5 public hospitals and 2 outpatient HIV clinics in Mexico (2015–2024). Participants had confirmed neurosyphilis, ocular syphilis, or otosyphilis. Participants received intravenous penicillin G (18–24 million IU/day) or ceftriaxone (1–2 g/day) for 10–14 days. The primary outcome was early serological response (ESR), defined as a ≥4-fold nontreponemal titer decline or seroreversion at 6 months. We performed 1:1 propensity score matching (39 pairs, n = 78), followed by logistic regression in the matched cohort.
Results
Of 143 participants, 104 (73%) received intravenous penicillin G and 39 (27%) ceftriaxone. In the matched cohort, ESR occurred in 74.4% of penicillin-treated participants and 71.8% of ceftriaxone-treated participants (odds ratio 0.88, 95% confidence interval .32–2.40; P = .80). The results were consistent across all prespecified sensitivity analyses.
Conclusions
In this multicenter cohort of people with HIV diagnosed with neurosyphilis, ocular syphilis, or otosyphilis, ceftriaxone showed comparable ESR to intravenous penicillin G. These findings support ceftriaxone as a reasonable alternative when standard therapy is limited by penicillin shortages, limited inpatient capacity, or financial constraints.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Subdirección de Investigación Biomédica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, México City, Mexico.
- Unidad de VIH, Hospital Civil de Guadalajara "Fray Antonio Alcalde," Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.
- Clínica de Inmunocompromiso por Enfermedades Infecciosas (CIENI), Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
- Clínica de Sífilis, Clínica Especializada Condesa Cuauhtémoc, Mexico City, Mexico.
- Departamento de Infectología, Clínica Especializada Condesa Iztapalapa, Mexico City, Mexico.
ORCID-Profile: Rodrigo Ville Benavides, Héctor Rivera-Villegas, Obed Ocampo-Valdez, Rafael Franco-Cendejas, Jaime Federico Andrade-Villanueva, Luz Alicia González-Hernández, Pedro Martínez-Ayala, Andrea Cárdenas-Ortega, Paulina Carreño-Pérez, Juan Carlos Rodríguez-Aldama, Edgar Pérez-Barragán, Pamela Alatorre-Fernández, Estefanía Sienra-Iracheta, Ana Patricia Rodríguez-Zulueta, Norma Eréndira Rivera-Martínez, Brenda Crabtree-Ramírez
Zitieren
APA
Ville Benavides, R., Rivera-Villegas, H., Ocampo-Valdez, O., Franco-Cendejas, R., Andrade-Villanueva, J. F., González-Hernández, L. A., Martínez-Ayala, P., Cárdenas-Ortega, A., Carreño-Pérez, P., Lezama-Mora, J., Rodríguez-Aldama, J. C., Pérez-Barragán, E., Alatorre-Fernández, P., Sienra-Iracheta, E., Rodríguez-Zulueta, A. P., Rivera-Martínez, N. E., & Crabtree-Ramírez, B. (2026). Penicillin or Ceftriaxone for Neurosyphilis in People With HIV: A Retrospective, Propensity Score–Matched Multicenter Study in Mexico. Open Forum Infectious Diseases, 13(7). https://doi.org/10.1093/ofid/ofag387
Vancouver
Ville Benavides R, Rivera-Villegas H, Ocampo-Valdez O, Franco-Cendejas R, Andrade-Villanueva JF, González-Hernández LA, et al. Penicillin or Ceftriaxone for Neurosyphilis in People With HIV: A Retrospective, Propensity Score–Matched Multicenter Study in Mexico. Open Forum Infectious Diseases. 2026;13(7). doi:10.1093/ofid/ofag387
BibTeX
@article{VilleBenavides2026,
author = {Ville Benavides, Rodrigo and Rivera-Villegas, Héctor and Ocampo-Valdez, Obed and Franco-Cendejas, Rafael and Andrade-Villanueva, Jaime Federico and González-Hernández, Luz Alicia and Martínez-Ayala, Pedro and Cárdenas-Ortega, Andrea and Carreño-Pérez, Paulina and Lezama-Mora, Jezer and Rodríguez-Aldama, Juan Carlos and Pérez-Barragán, Edgar and Alatorre-Fernández, Pamela and Sienra-Iracheta, Estefanía and Rodríguez-Zulueta, Ana Patricia and Rivera-Martínez, Norma Eréndira and Crabtree-Ramírez, Brenda},
title = {Penicillin or Ceftriaxone for Neurosyphilis in People With HIV: A Retrospective, Propensity Score–Matched Multicenter Study in Mexico},
journal = {Open Forum Infectious Diseases},
year = {2026},
volume = {13},
number = {7},
doi = {10.1093/ofid/ofag387}
}
EUVIMED